Postmarketing Surveillance of In-vitro Diagnostic System in the European Union

Author(s): Singh Himadri*

Journal Name: Applied Drug Research, Clinical Trials and Regulatory Affairs
(Formerly Applied Clinical Research, Clinical Trials and Regulatory Affairs)

Volume 8 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Advances in medical device technology and regulatory authorization adapt to changing requirements and market conditions. The assessment of safety and performance in the real-world scenario will help us understand clinical benefits and help in the evolution of the medical device and in-vitro diagnostic devices. The paradigm shift in the evaluation of medical devices and in vitro diagnostic devices will ensure that the device delivers intended benefits. This article discusses the new approach of the post-marketing surveillance in the context of new in vitro diagnostic regulation in the European Union.

Keywords: European regulation, in vitro, diagnostics, regulation, post market, risk benefit, medical device.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 1
Year: 2021
Published on: 13 October, 2020
Page: [48 - 52]
Pages: 5
DOI: 10.2174/2213476X07666201013161551
Price: $65

Article Metrics

PDF: 4